Needham & Company Starts Phathom Pharmaceuticals (PHAT) at Buy, Street High $40 PT
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
Evercore ISI Starts Phathom Pharmaceuticals (PHAT) at Outperform
November 19, 2019 8:27 PM ESTEvercore ISI analyst Umer Raffat initiates coverage on Phathom Pharmaceuticals (NASDAQ: PHAT) with a Outperform rating.
For an analyst ratings summary and ratings history on Phathom Pharmaceuticals click here. For more ratings news on Phathom Pharmaceuticals click here.
Shares of Phathom Pharmaceuticals closed at $24.27 yesterday.
... MoreJefferies Starts Phathom PharmaceuticalsPharmaceuticals (PHAT) at Buy
November 19, 2019 4:42 AM ESTJefferies analyst David Steinberg initiates coverage on Phathom PharmaceuticalsPharmaceuticals (NASDAQ: PHAT) with a Buy rating and a price target of $32.00.
For an analyst ratings summary and ratings history on Phathom PharmaceuticalsPharmaceuticals click here. For more ratings news on Phathom PharmaceuticalsPharmaceuticals click here.
Shares of Phathom PharmaceuticalsPharmaceuticals closed at $24.27 yesterday.
... MoreGoldman Sachs Starts Phathom Pharmaceuticals (PHAT) at Neutral
November 19, 2019 4:41 AM ESTGoldman Sachs analyst Paul Choi initiates coverage on Phathom Pharmaceuticals (NASDAQ: PHAT) with a Neutral rating and a price target of $32.00.
For an analyst ratings summary and ratings history on Phathom Pharmaceuticals click here. For more ratings news on Phathom Pharmaceuticals click here.
Shares of Phathom Pharmaceuticals closed at $24.27 yesterday.
... More